Cancer
Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA and at Northwest Biotherapeutics, Inc. has found that a personalized...
Checkpoint inhibitor shrinks advanced squamous cell skin cancer
Credit: MD Anderson Cancer Center HOUSTON - Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly...
NCI-MATCH precision medicine clinical trial releases new findings
Chicago, Monday, June 4, 2018 -- The National Cancer Institute's Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision...
Childhood cancer: The four survival strategies of tumor cells
Cancer cells in children tend to develop by following four main trajectories - and two of them are linked to...
First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients
Credit: MD Anderson Cancer Center CHICAGO - In a small Phase II study of early-stage breast cancer patients with BRCA1/2...
The role of cohesin in genome 3D structure helps for a better understanding of tumor cells
In recent years it has become evident that the spatial organisation of the genome is key for its function. This...
New approach to immunotherapy leads to complete response in breast cancer patient
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression...
Timing is everything to build kidneys from scratch
Credit: Image by Nils O. Lindstrom and Tracy Tran/McMahon Lab USC Stem Cell Arriving early or late can have big...
Cervical cancer may be driven by imbalance in vaginal bacteria, UA research finds
Credit: Herbst-Kralovetz lab Virtually all cervical cancers are caused by HPV, or human papillomavirus, dubbed the "common cold" of sexually...
More frequent screening after prostate cancer treatment not linked to improved survival
CHICAGO -- Prostate cancer patients who were monitored more frequently after treatment did not live significantly longer than patients who...
New study points to a potential ‘Achilles heel’ in brain cancer
Credit: VCU Massey Cancer Center Scientists at Virginia Commonwealth University believe they have uncovered an "Achilles heel" of glioblastoma multiforme...
Two-step process underpins upkeep of key protein in cell division
Scientists have shed light on a key aspect of healthy cell division, helping build a clearer picture of the complex...
A great majority of Mozambican adolescent girls are willing to be vaccinated against HPV
Credit: ISGlobal The highest burden of cervical cancer is concentrated in sub-Saharan Africa, where it is the main cause of...
Childhood cancer survivors more likely to experience sleep problems as adults
Preliminary results from a study of childhood cancer survivors show that they are more likely to experience sleep problems and...
ASCO: ALEX trial results show alectinib further outpacing crizotinib in ALK+ NSCLC
Credit: University of Colorado Cancer Center Updated results of the global phase III ALEX trial comparing alectinib with crizotinib as...
ASCO18: Updated Phase 1 results of crizotinib against MET-amplified lung cancer
Credit: University of Colorado Cancer Center The drug crizotinib has activity against a number of genetic targets relevant to non-small...
ASCO18: Trial shows how PET scans help tailor therapy for esophageal cancer
Credit: University of Colorado Cancer Center Survival results for the CALGB 80303 Trial presented today at the American Society of...
ASCO18: Positive results for phase 1 trial of ivosidenib against AML
Credit: University of Colorado Cancer Center Early phase clinical trial results presented today at the American Society of Clinical Oncology...
How might baking soda boost cancer therapy?
MAY 31, 2018, NEW YORK -- A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which cells...
Cleveland Clinic Cancer Center experts present data at 2018 ASCO Annual Meeting
Friday, June 1, 2018, CLEVELAND: At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, researchers from Cleveland...
